- Goldwind’s net income for the fiscal year was 1.86 billion yuan.
- This net income figure fell short of analyst estimates, which were 2.59 billion yuan.
- The company’s revenue reached 56.70 billion yuan, marking a 12% increase year-over-year.
- Revenue slightly missed estimates of 57.28 billion yuan.
- Analyst ratings for Goldwind include 16 buys, 2 holds, and 0 sells.
- All comparisons are made against values from the company’s original disclosures.
A look at Xinjiang Goldwind Science & Technology Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts are optimistic about the long-term outlook for Xinjiang Goldwind Science & Technology Co., Ltd., a company that specializes in manufacturing wind generator sets and providing consulting services for wind generating plants. With a top score in the Value category, Xinjiang Goldwind is perceived as having strong value potential. Additionally, the company has moderate scores in Dividend and Growth, indicating a stable approach to dividends and growth prospects. However, its scores in Resilience and Momentum are lower, suggesting some challenges in terms of resilience and momentum in the market.
Xinjiang Goldwind’s strong Value score reflects the company’s solid fundamentals and potential for value creation over the long term. While the company may face some resilience and momentum challenges, its focus on manufacturing wind generator sets and operating wind generating plants positions it well in the renewable energy sector. Investors will likely keep an eye on how Xinjiang Goldwind navigates these challenges while capitalizing on its strong value proposition in the marketplace.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
